Athersys to Present at Needham Healthcare Conference on April 4
March 29 2017 - 4:00PM
Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen,
Chairman and CEO, will present a corporate overview at the 16th
Annual Needham Healthcare Conference at The Westin New York Grand
Central Hotel in New York City. The presentation is scheduled
for Tuesday, April 4, 2017 at 12:10 pm ET.
Investors interested in arranging a meeting with
the Company's management during this conference should contact the
conference coordinator.
A live webcast of the presentation can be
accessed by visiting ‘Events & Presentations’ in the Investors
Section on the Company's website at www.athersys.com. An archived
replay of the webcast will be available for 90 days on the
Company's website after the conference.
About Athersys
Athersys is an international biotechnology
company engaged in the development of therapeutic products designed
to extend and enhance the quality of human life. The Company is
developing its MultiStem® cell therapy product, a patented,
adult-derived "off-the-shelf" stem cell product, initially for
disease indications in the neurological, cardiovascular, and
inflammatory and immune disease areas, and has several ongoing
clinical trials evaluating this potential regenerative medicine
product. Athersys has forged strategic partnerships and a broad
network of collaborations to further advance MultiStem cell therapy
toward commercialization. More information is available at
www.athersys.com. Follow Athersys on Twitter at
www.twitter.com/athersys.
ATHX-G
Contact:
William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
bjlehmann@athersys.com
David Schull
Russo Partners, LLC
Tel: (212) 845-4271 or (858) 717-2310
David.schull@russopartnersllc.com
Investor Contact:
Peter Vozzo
Westwicke Partners
(443) 213-0505 or (443) 377-4767 (mobile)
Peter.vozzo@westwicke.com
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Sep 2023 to Sep 2024